Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Neurosurgery. 2013 Mar;72(3):428-35; discussion 435-6. doi: 10.1227/NEU.0b013e3182804381.
Giant middle cerebral artery (MCA) aneurysms pose management challenges.
To review the outcomes of patients with giant MCA aneurysms not amenable to clipping or vessel reconstruction treated with extracranial-intracranial (EC-IC) bypass and vessel sacrifice.
We retrospectively reviewed a database of aneurysms treated at our institution between 1983 and 2011.
Sixteen patients (11 males, 5 females) were identified. There were 10 saccular, 4 fusiform, and 2 serpentine aneurysms. The aneurysms predominantly involved the M1 segment in 5 cases, M2 in 9 cases, and both M1 and M2 in 2 cases. The EC-IC bypasses performed included 13 superficial temporal artery-MCA, 1 saphenous vein graft-MCA, and 2 radial artery grafts-MCA. The postoperative bypass patency rate was 93.8% (15/16). There were 3 cerebrovascular accidents (18.8%), but no perioperative deaths (0% mortality). The mean follow-up was 58.4 months (range, 1-265; median, 23.5 months). In 75% (12/16) of cases the aneurysms were occluded successfully. A small residual was noted in 3 cases with the use of this treatment strategy, and they were re-treated. In a fourth case treated with partial distal occlusion, reduced flow through the aneurysm was noted postoperatively, but the patient did not undergo further treatment. The mean modified Rankin scale and mean Glasgow Outcome Scale scores at last follow-up were 1.6 (range, 1-4; median, 1) and 4.8 (range, 3-5; median, 5), respectively.
Giant MCA aneurysms are challenging lesions. EC-IC bypass with parent vessel occlusion can provide a durable form of treatment with acceptable rates of morbidity and mortality.
巨大大脑中动脉(MCA)动脉瘤的治疗颇具挑战性。
分析无法夹闭或血管重建的巨大 MCA 动脉瘤患者行颅外-颅内(EC-IC)旁路和血管牺牲的治疗效果。
我们回顾性分析了 1983 年至 2011 年在我院治疗的动脉瘤数据库。
共纳入 16 例患者(11 例男性,5 例女性)。10 例为囊状,4 例为梭形,2 例为蛇形动脉瘤。动脉瘤主要位于 M1 段 5 例,M2 段 9 例,M1 和 M2 段均累及 2 例。实施的 EC-IC 旁路包括 13 例颞浅动脉-MCA 吻合术、1 例隐静脉-MCA 移植术和 2 例桡动脉-MCA 移植术。术后旁路通畅率为 93.8%(15/16)。术后发生 3 例脑血管意外(18.8%),但无围手术期死亡(死亡率为 0%)。平均随访时间为 58.4 个月(范围,1-265 个月;中位数,23.5 个月)。75%(12/16)的病例成功闭塞了动脉瘤。3 例采用该治疗策略后发现动脉瘤残留较小,再次进行治疗。第 4 例采用部分远端闭塞治疗的患者,术后发现动脉瘤内血流减少,但未进一步治疗。末次随访时平均改良 Rankin 量表和平均 Glasgow 预后量表评分为 1.6(范围,1-4;中位数,1)和 4.8(范围,3-5;中位数,5)。
巨大 MCA 动脉瘤是具有挑战性的病变。EC-IC 旁路伴载瘤动脉闭塞可为患者提供一种持久的治疗方式,其发病率和死亡率可接受。